Schubert & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101
Closed -$5.05K 252
2023
Q1
$5.05K Buy
101
+3
+3% +$141 ﹤0.01% 448
2022
Q4
$4.53K Buy
98
+7
+8% +$303 ﹤0.01% 473
2022
Q3
$4K Buy
91
+38
+72% +$1.52K ﹤0.01% 468
2022
Q2
$2K Buy
53
+16
+43% +$651 ﹤0.01% 716
2022
Q1
$2K Buy
37
+10
+37% +$433 ﹤0.01% 357
2021
Q4
$1K Buy
+27
New +$1.14K ﹤0.01% 548

Other funds holding BSX

Schubert & Co's BSX Position: Q2 2023 in Review

Schubert & Co sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 101 shares — an estimated $5.05K sold.

Schubert & Co first reported a position in BSX in Q4 2021 and held it in 6 quarters. The position peaked at $5.05K in Q1 2023. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Schubert & Co reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 101 Boston Scientific shares in Q2 2023, an estimated $5.05K.
  • Schubert & Co first reported a position in Boston Scientific in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Boston Scientific position peaked at $5.05K in Q1 2023.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.